Searched for
SPUTNIK V SALES
Local drug companies in a fix over Sputnik amid sanctions against RDIFRDIF is commercialising the Sputnik vaccine globally, which was developed by Russia's Gamaleya Research Institute.- Panacea Biotec hits 5% upper circuit after Mankind Pharma dealAs part of this arrangement, Mankind Pharma is retaining Panacea's sales and marketing team engaged in the particular business.
- Dr Reddy’s Q2 results: Consolidated PAT rises 30% YoY, beats estimateThe drugmaker reported an 18 per cent on-year rise in consolidated revenues to Rs. 5,763 crore for the reported quarter, which also beat St...
- Floundering private sales of vaccine in India deal blow to Russia's Sputnik VSome industry officials said low demand and the extremely cold storage temperatures required have spurred at least three big hospitals to c...
- Stocks in the news: HDFC Bank, DRL, Ceat, Coal India and NFLHDFC Bank said it has signed a pact with the National Small Industries Corporation for providing credit support to the MSME sector.
- Dr Reddy's starts supply of Sputnik V first dosesThe city-based drug maker also launched website to keep the public updated on the availability of the Sputnik V vaccine the site (www.drred...
- Panacea Biotec supplies second component of Sputnik V vaccine in IndiaThe second component of Sputnik V has been manufactured at the company's vaccine manufacturing facility in Himachal Pradesh, Panacea Biotec...
- Rockwell Industries ties up with DRL for freezers to store Sputnik V vaccineThe vaccine freezer plays a very critical role in the safety of vaccines and its potency as Russias Sputnik Vaccine, made available in Indi...
- Human race facing existential crisis in COVID-19 pandemic: Delhi High CourtThe high court, which was dealing with the issue of Sputnik V vaccine, also said going by the rule book to save human lives in these extrao...
- COVID-19: Delhi High Court anguished over shortage of vaccines in IndiaThe high court was deliberating with the issue related to manufacturing of COVID vaccine Sputnik V by India's Panacea Biotec in collaborati...
- Stock of Indian Sputnik V maker gets a shot in the arm; analysts see long runwayThe company reported 34 per cent growth in consolidated net profit at Rs 260.4 crore for March quarter on robust sales.
- Sputnik V could be available in India from next week: NITI AayogNotably, Sputnik V is the third vaccine India has given go-ahead to after Covishield, developed by Oxford University and AstraZeneca and Co...
- Russia, facing lags, turns to China to produce Sputnik shotsRussia has announced three deals totaling 260 million doses with Chinese vaccine companies in recent weeks. It's a decision that could mean...
- Bharat Biotech seeks Drugs Controller General of India's nod to extend shelf life of CovaxinThe Hyderabad-based Bharat Biotech was given permission for sale and distribution of Covaxin with shelf life of six months when stored at t...
- Sputnik V will be subject to price controls: Government officialsWhile local companies will be able to determine price of Sputnik for export, domestic sales must be affordable, officials said.
- Dr Reddy’s may mop up $300 million in Sputnik V salesThe company has exclusive marketing and distribution rights for the first 250 million doses of Sputnik V vaccines in the country. This is a...
- Can Sputnik V approval bring big gains to Dr Reddy’s stock?Analysts said Dr Reddy’s Labs has exclusive distribution rights for the first 250 million doses in India.
- Dr Reddy’s Q3 results: Net profit at Rs 19.8 crore, sharply lower than Street estimatesThe company’s consolidated revenues grew 12 per cent on year to Rs. 4,930 crore, which was largely in-line with analysts’ estimate of Rs. 4...
- Indian partners to make Russian vaccine for supply to ArgentinaThe announcement came on Tuesday when the President of Argentina Alberto Fernandez said in an interview his country will be getting supply ...
- Mankind pharma collaborates with Russian RDIF for distribution of Sputnik V in IndiaEarlier in September, Dr. Reddy’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution ...
Load More
